A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Clinical trial NCT05696613 · RECRUITING
Trial details
- NCT number
- NCT05696613
- Sponsor
- Cerium Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2027-04-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.